HAO (Haoxi Health Technology Co., Ltd.) Total Enterprise Value

Haoxi Health Technology (HAO) revenues rely on the budgets of the PRC pharmaceutical sector, rendering the business cyclical, although the digitalization of medicine supports growth. The environmental footprint is minimal and limited to the energy consumption of servers and offices. This chart of the company's valuation history on GURU.Markets, reaching -8.34, highlights the agency's resilience driven by a unique client base in the healthcare IT sector under strict government supervision.

The digitalization of pharmaceutical marketing and the integration of AI targeting into the Haoxi Health Technology (HAO) business model directly impact the asset's investment attractiveness. Enterprise value is calculated as the sum of market capitalization and net debt, reflecting the actual cost of a full business buyout. This metric allows for an assessment of the company's fundamental resilience to external shocks. It is critical for investors to monitor the balance between liabilities and liquidity. Analyzing enterprise value forecasts helps determine the risk of overpaying for the asset.